Read beyond the mushroom name.
A randomized trial examined Ganoderma lucidum for cardiovascular risk factors in metabolic syndrome. Its preparation, participants and endpoints matter; an ingredient study is not a clinical trial of KUZŪ.
Read the randomized trial ↗
